MCM
CELG

Maryland Capital Management’s Celgene Corp CELG Stock Holding History

Maryland Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-95,949
Closed -$10M – 178
2017
Q4 		$10M Buy
95,949
+11,752
+14% +$1.33M 1.48% 23
2017
Q3 		$12.3M Buy
84,197
+81,287
+2,793% +$11.1M 1.89% 21
2017
Q2 		$378K Buy
2,910
+890
+44% +$109K 0.05% 133
2017
Q1 		$251K Buy
+2,020
New +$242K 0.04% 154

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Maryland Capital Management's CELG Position: Q1 2018 in Review

Maryland Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 95,949 shares — an estimated $10M sold.

Maryland Capital Management first reported a position in CELG in Q1 2017 and held it in 4 quarters. The position peaked at $12.3M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Maryland Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Maryland Capital Management sold 95,949 Celgene Corp shares in Q1 2018, an estimated $10M.
  • Maryland Capital Management first reported a position in Celgene Corp in Q1 2017 and held it in 4 quarters.
  • Maryland Capital Management's Celgene Corp position peaked at $12.3M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Maryland Capital Management's 13F filing for Q1 2018, filed 14 May 2018.